3M4I image
Entry Detail
PDB ID:
3M4I
Keywords:
Title:
Crystal structure of the second part of the Mycobacterium tuberculosis DNA gyrase reaction core: the TOPRIM domain at 1.95 A resolution
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2010-03-11
Release Date:
2010-09-29
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.22
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:DNA gyrase subunit B
Chain IDs:A
Chain Length:242
Number of Molecules:1
Biological Source:Mycobacterium tuberculosis
Ligand Molecules
Primary Citation
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
Plos One 5 e12245 e12245 (2010)
PMID: 20805881 DOI: 10.1371/journal.pone.0012245

Abstact

Mycobacterium tuberculosis DNA gyrase, an indispensable nanomachine involved in the regulation of DNA topology, is the only type II topoisomerase present in this organism and is hence the sole target for quinolone action, a crucial drug active against multidrug-resistant tuberculosis. To understand at an atomic level the quinolone resistance mechanism, which emerges in extensively drug resistant tuberculosis, we performed combined functional, biophysical and structural studies of the two individual domains constituting the catalytic DNA gyrase reaction core, namely the Toprim and the breakage-reunion domains. This allowed us to produce a model of the catalytic reaction core in complex with DNA and a quinolone molecule, identifying original mechanistic properties of quinolone binding and clarifying the relationships between amino acid mutations and resistance phenotype of M. tuberculosis DNA gyrase. These results are compatible with our previous studies on quinolone resistance. Interestingly, the structure of the entire breakage-reunion domain revealed a new interaction, in which the Quinolone-Binding Pocket (QBP) is blocked by the N-terminal helix of a symmetry-related molecule. This interaction provides useful starting points for designing peptide based inhibitors that target DNA gyrase to prevent its binding to DNA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures